GSA CAPITAL PARTNERS LLP

Holdings History for Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

Symbol: SPRO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.04%	+0.01%	$417,000	178,930	+72,036	+67%	$2.33	Q4 2025
30 Sep 2025	0.02%	+0.02%	$201,000	106,894	+106,894	NEW	$1.88	Q3 2025
30 Jun 2024		-0%	$0	0	-28,319	-100%	$2.37	Q2 2024
31 Mar 2024	0%	+0%	$49,000	28,319	+28,319	NEW	$1.73	Q1 2024
30 Sep 2022		-0%	$0	0	-10,450	-100%	$2.37	Q3 2022
30 Jun 2022	0%	-0%	$8,000	10,450	-15,466	-60%	$0.77	Q2 2022
31 Mar 2022	0.03%	+0.03%	$225,000	25,916	+25,916	NEW	$8.68	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.